2025-2026 Regular Session • Nebraska Legislature
LB475
Legislative Summary
Classify tianeptine as a controlled substance
Demographic Impact
Overall analysis of equity impact
70% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/21/2025
Date of introduction
Legislature
1/23/2025
Referred to Judiciary Committee
Legislature
2/6/2025
Notice of hearing for February 28, 2025
Legislature
3/13/2025
Placed on General File with AM572
Legislature
3/13/2025
Judiciary AM572 filed
Legislature
5/30/2025
Motion to suspend rules to indefinitely postpone filed
Legislature
Amendments
Judiciary AM572
Judiciary AM572
3/13/2025Not Adopted
Status Information
Current Status
Introduced(1/21/2025)
Chamber
Legislature
Sponsors
Nonpartisan: 1
Primary Sponsor
Merv Riepe
Nonpartisan